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The Dynamics of the Rapsyn Scaffolding Protein at Individual Acetylcholine
Receptor Clusters
Abstract
Rapsyn, a cytoplasmic receptor-associated protein, is required for the clustering of acetylcholine
receptors (AChRs). Although AChR dynamics have been extensively studied, little is known about the
dynamics of rapsyn. Here, we used a rapsyn-green fluorescent protein (GFP) fusion protein and
quantitative fluorescent imaging to study the dynamics of rapsyn in transfected C2C12 myotubes. First,
we found that rapsyn-GFP expression at clusters did not alter AChR aggregation, function, or turnover.
Quantification of rapsyn immunofluorescence indicated that the expression of rapsyn-GFP proteins at
clusters does not increase the overall rapsyn density compared with untransfected myotube clusters.
Using time lapse imaging and fluorescence recovery after photobleaching, we demonstrated that the
recovery of rapsyn-GFP fluorescence at clusters was very fast, with a halftime of about ∼1.5 h (∼3 times
faster than AChRs). Inhibition of protein kinase C significantly altered receptor insertion, but it had no
effect on rapsyn insertion. When cells were treated with the broad spectrum kinase inhibitor
staurosporine, receptor insertion was decreased even further. However, inhibition of protein kinase A had
no effect on insertion of either rapsyn or receptors. Finally, when cells were treated with neural agrin,
rapsyn and AChRs were both directed away from preexisting clusters and accumulated together in new
small clusters. These results demonstrate the remarkable dynamism of rapsyn, which may underlie the
stability and maintenance of the postsynaptic scaffold and suggest that the insertion of different
postsynaptic proteins may be operating independently.
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Rapsyn, a cytoplasmic receptor-associated protein, is
required for the clustering of acetylcholine receptors (AChRs).
Although AChR dynamics have been extensively studied, little is
known about the dynamics of rapsyn. Here, we used a rapsyngreen fluorescent protein (GFP) fusion protein and quantitative
fluorescent imaging to study the dynamics of rapsyn in transfected C2C12 myotubes. First, we found that rapsyn-GFP
expression at clusters did not alter AChR aggregation, function,
or turnover. Quantification of rapsyn immunofluorescence
indicated that the expression of rapsyn-GFP proteins at clusters
does not increase the overall rapsyn density compared with
untransfected myotube clusters. Using time lapse imaging and
fluorescence recovery after photobleaching, we demonstrated
that the recovery of rapsyn-GFP fluorescence at clusters was
very fast, with a halftime of about ⬃1.5 h (⬃3 times faster than
AChRs). Inhibition of protein kinase C significantly altered
receptor insertion, but it had no effect on rapsyn insertion.
When cells were treated with the broad spectrum kinase inhibitor staurosporine, receptor insertion was decreased even further. However, inhibition of protein kinase A had no effect on
insertion of either rapsyn or receptors. Finally, when cells were
treated with neural agrin, rapsyn and AChRs were both directed
away from preexisting clusters and accumulated together in new
small clusters. These results demonstrate the remarkable
dynamism of rapsyn, which may underlie the stability and
maintenance of the postsynaptic scaffold and suggest that the
insertion of different postsynaptic proteins may be operating
independently.

The efficacy of synaptic transmission depends upon the high
density and number of postsynaptic neurotransmitter receptors at sites of neurotransmitter release (1, 2). This density can
be maintained in several ways. For example, phosphorylation/
dephosphorylation events mediated by different kinases are
able to alter receptor synthesis and dynamics (2–5), and a number of postsynaptic scaffolding proteins have been found to be
essential either for the clustering or the maintenance of
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postsynaptic receptors at cluster sites at both central and
peripheral synapses (2, 6 –11).
The formation of the postsynaptic receptor density is best
studied at the neuromuscular junction. Among the molecules
involved in the clustering of AChRs2 is rapsyn. Rapsyn (43 kDa)
was initially purified from the torpedo electric organ and is
thought to be associated with AChRs in a 1:1 stoichiometry at
the muscle surface (12, 13). Rapsyn is responsible for mediating
the effect of agrin, a neuronal clustering factor that activates the
muscle-specific kinase and initiates AChR clustering in a tyrosine kinase-dependent manner (14 –18). In mice lacking
rapsyn, receptor clustering does not occur, and neuromuscular
junctions fail to form (19). Rapsyn mutations also cause AChR
deficiency in patients with congenital myasthenia syndrome
(20 –22), highlighting the importance of rapsyn for the formation and organization of the postsynaptic receptor density.
Although the availability of highly specific receptor ligands has
enabled the study of AChR dynamics on the living muscle in
vitro and in vivo (23, 24), the study of scaffolding protein
dynamics at postsynaptic density has been hindered by their
inaccessibility to extracellular ligands.
In this study, we investigated the dynamics of rapsyn at individual clusters on cultured myotubes. Our interest specifically
in rapsyn stems from its close association with AChRs and its
role in receptor clustering at the postsynaptic membrane. By
monitoring the fluorescence of rapsyn-GFP fusion proteins
clustered on the surface of transfected C2C12 myotubes, we
were able to determine that rapsyn is markedly more dynamic
than AChRs and is not affected by pharmacological manipulation that alters AChR dynamics, although both rapsyn and
AChRs are similarly modulated by the nerve clustering factor,
agrin.

EXPERIMENTAL PROCEDURES
GFP Fusion Construct—The rapsyn-GFP fusion construct
was kindly provided by Dr. Jonathan Cohen (Harvard Medical
School).
Cell Culture—To generate laminin-coated dishes, 5 g/ml
polyornithine (Sigma) was added to 35-mm culture dishes and
allowed to evaporate overnight. The following day, 10 g/ml of
EHS laminin (Invitrogen) in L-15 medium supplemented with
0.2% sodium bicarbonate was added to the dishes, and they
were placed in an incubator overnight until ready for plating.
2

The abbreviations used are: AChR, acetylcholine receptor; GFP, green fluorescent protein; PKA, protein kinase A; PKC, protein kinase C; BTX, bungarotoxin; BTX-488, bungarotoxin-Alexa 488.
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C2C12 myoblasts (ATCC, Manassas, VA) were plated and then
grown in 20% fetal bovine serum with penicillin and streptomycin in Dulbecco’s modified Eagle’s medium. Cells were transfected at 70 –100% confluence with 1 g of rapsyn-GFP using
FUGENE6 transfection reagent (Roche Applied Science). Cells
were then differentiated by replacing the fetal bovine serum
solution with 5% horse serum medium with penicillin and
streptomycin in Dulbecco’s modified Eagle’s medium. Medium
was changed every 2 days, and cells were imaged 3– 4 days after
differentiation.
Immunofluorescence Microscopy—Transfected myotubes
were fixed with 2% paraformaldehyde and then treated for 20
min with 1% Triton X-100 in phosphate-buffered solution.
Cells were then incubated with mouse anti-rapsyn primary
(monoclonal antibody 1234; Sigma) and goat anti-mouse Alexa
594 secondary antibodies (Invitrogen). After extensive washing, cells were imaged. Background fluorescence was approximated by selecting a boundary region around the cluster and
subtracting it from the original image, and the mean of the total
fluorescence intensity (which corresponds to density) was
measured. Image analysis was performed by using a procedure
written for Matlab (The Mathworks, Natick, MA) (25). The
acquisition and quantification of images were done with the
experimenter blind to rapsyn-GFP expression at each cluster.
Electrophysiology—A rapsyn-GFP-transfected myotube was
located, and a whole cell patch clamp recording was obtained
under voltage clamp. The AChR agonist carbachol (100 M)
was then ejected into the medium with a puffer pipette placed
near the patched cell, and the resulting inward current was
measured. As a control for the specificity of carbachol, the
AChR antagonist curare (10 M) was applied by perfusion into
the cell medium to block these inward currents. Measurements were made as above on untransfected myotubes for
comparison.
Receptor Loss—AChR loss was determined by labeling
AChRs of untransfected myotubes or myotubes expressing
rapsyn-GFP with bungarotoxin-Alexa 594 (5 g/ml, 1 h). Initial
images of rapsyn-GFP and/or clustered receptors were taken,
and 4 h later, the same clusters were found and reimaged. The
loss of fluorescence was then assayed using quantitative fluorescence imaging (24, 26). Clusters expressing different levels of GFP were then grouped into three categories according
to mean GFP expression: low (0 –25th percentile of mean
fluorescence), medium (26 – 49th percentile), and high (50 –
100th percentile).
Fluorescent Recovery after Photobleaching—To determine
the insertion of rapsyn into receptor clusters over time, the
green fluorescence at individual rapsyn-GFP-expressing clusters was removed by illuminating the cluster with an argon laser
passed through a neutral density filter that blocked 50% of the
light. Laser illumination of myotube clusters has been shown
previously not to affect receptor dynamics or muscle cell integrity
(8, 23). The recovery of fluorescence was assayed, and the amount
of fluorescence recovered at each cluster was measured.
To determine the insertion of AChRs into clusters over time,
receptors on untransfected myotubes were saturated with bungarotoxin-Alexa 488 (BTX-488) (5 g/ml, 1 h) (Molecular
Probes, Inc., Eugene, OR), and the green fluorescence was comMARCH 30, 2007 • VOLUME 282 • NUMBER 13

pletely removed with an argon laser. Since newly synthesized
receptors inserted into the cluster over time were unlabeled,
BTX-488 was then added before each time point to label these
receptors, excess BTX-488 was washed away, and the clusters
were again imaged (as described by Bruneau et al. (23)). In this
way, the total insertion of receptors (both previously labeled
receptors that had laterally migrated into the cluster and the
newly labeled receptors that had been inserted into the cluster)
could be determined and compared with the insertion and lateral migration of rapsyn-GFP. For the purposes of this paper,
“insertion” will refer to the accumulation of proteins at clusters
both through direct incorporation from intracellular locations
and from the lateral migration of surface-associated proteins.
Agrin Treatment—To determine the effect of agrin on
rapsyn-GFP expression at clusters, myotubes grown on laminin-coated dishes transfected with rapsyn-GFP were incubated
with BTX-594 to label all AChRs. After initial images were
taken, 100 ng/ml C-terminal agrin (R & D Systems, Minneapolis, MN) was added to the culture dish. At 4 and 8 h, images were
taken to determine the location of rapsyn-GFP and AChRs.
Kinase Inhibition—To determine the effect of various kinase
inhibitors on rapsyn-GFP insertion over time, the GFP signal
from clusters on myotubes transfected with rapsyn-GFP was
carefully removed with an argon laser, and one of the following
drugs was added to the medium: 100 nM H-89 (to block PKA),
20 M H-89 (to inhibit both PKA and PKC), 10 nM calphostin C
(to inhibit PKC), or 20 nM staurosporine (to block a broad spectrum of kinases, including PKA and PKC) (drug specificity
obtained from the manufacturer, Sigma). Images were taken
immediately before and after photobleaching, and 4 h later, the
same clusters were reimaged, and the fluorescent intensity at
bleached and nonbleached clusters was determined. RapsynGFP recovery was determined by comparing the GFP signal at
bleached clusters after 4 h with their fluorescence immediately
prior to bleaching. Since the expression of rapsyn-GFP was
variable over time and between different myotubes in these
experiments, rapsyn-GFP insertion at each cluster was normalized to the changes in expression (if any) at control, unbleached
clusters on the same myotube. Overall changes in expression in
each culture dish were comparable across all treatment groups.
We also performed a series of experiments to determine the
loss and insertion of receptors at individual clusters in the presence of the same pharmacological agents. To measure the
insertion rate of receptors, untransfected myotubes were saturated with BTX-488 (5 g/ml, 1 h), and the fluorescence was
carefully removed from individual clusters with an argon laser.
Initial images were taken, and one of the above kinase inhibitors
was added to the cultures. Four hours later, after incubating
with new BTX-488 to label new receptors inserted since initial
imaging, the same clusters were found and imaged. The insertion
of AChRs was determined by comparing cluster fluorescence at
4 h with the original fluorescence prior to bleaching.
To measure the loss rate of receptors, untransfected myotubes were saturated with BTX-488 (5 g/ml, 1 h), and individual clusters were immediately imaged and incubated with one
of the above mentioned inhibitors. The same clusters were
then reimaged 4 h later, and their fluorescence intensity was
measured.
JOURNAL OF BIOLOGICAL CHEMISTRY
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RESULTS
Rapsyn-GFP Does Not Affect Acetylcholine Receptor Clustering, Function, or Removal Rate—First, in order to verify that
rapsyn-GFP was able to localize to laminin-associated AChR
clusters on our cultured myotubes, we transiently transfected
C2C12 myoblasts with a rapsyn-GFP fusion protein (27). Three
to four days after differentiation into myotubes, cultured cells
were bathed with bungarotoxin conjugated to Alexa 594 (BTX594) to label AChRs, and receptor clusters were imaged.
Rapsyn-GFP clusters were found to always perfectly co-localize
with AChRs (Fig. 1A).
We also wanted to determine if the insertion and accumulation of rapsyn-GFP at laminin-induced receptor clusters
affected AChR function. To examine this question, we compared inward current across the muscle membrane in response
to the application of the AChR agonist, carbachol, on myotubes
expressing rapsyn-GFP and nontransfected myotubes. Under
direct visual control, we obtained a whole cell patch on a myotube, clamped voltage, and stimulated with carbachol. We
found that the inward currents were similar in both transfected
and untransfected cells and were both completely blocked by
the addition of the AChR antagonist curare (Fig. 1B). These
results indicate that the surface expression of rapsyn-GFP does
not disrupt receptor function.
Next, we asked whether the overall density of rapsyn molecules at clusters (endogenous rapsyn plus exogenous rapsynGFP) was increased by rapsyn-GFP expression in transfected
myotubes. To examine this, myotube cultures that were transfected with rapsyn-GFP were fixed and permeabilized and then
immunostained with an anti-rapsyn antibody. We used an antirapsyn antibody that has been shown previously to recognize
both rapsyn and rapsyn-GFP fusion proteins (28). Since transfection efficiency of myotubes in each culture dish was variable,
we were able to use the same culture dish to determine the
relative number of rapsyn molecules at nontransfected clusters
and at rapsyn-GFP-expressing clusters over a wide range of
expression levels (Fig. 1C). Quantitative analysis of the mean
fluorescence intensity of anti-rapsyn immunostaining revealed
that the average density of total rapsyn at rapsyn-GFP-expressing clusters was 12.5 ⫾ 3.2 (S.D.) (arbitrary units), n ⫽ 198. This
is nearly identical to the density at clusters containing only
endogenous rapsyn (11.8 ⫾ 3.2 (S.D., n ⫽ 123) (Fig. 1, C–E).
Even over a nearly 10-fold range of rapsyn-GFP expression at
clusters, the difference in total rapsyn density was negligible
(Fig. 1E). It is possible that the number of rapsyn-GFP molecules
at transfected clusters is negligible compared with the total
number of endogenous rapsyn molecules. In this case, the
presence of exogenous rapsyn-GFP would not detectably
alter overall rapsyn density. Alternatively, it is possible that
exogenous rapsyn-GFP replaces the endogenous rapsyn,
allowing overall rapsyn density at clusters to remain constant (see “Discussion”).
Finally, we wanted to determine whether rapsyn-GFP
expression levels at clusters had any effect on AChR stability.
To do this, transfected myotubes were saturated with BTX-594,
and receptor loss was monitored at clusters expressing low,
medium, and high levels of rapsyn-GFP on two separate myo-
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FIGURE 1. Rapsyn-GFP cluster expression does not alter AChR clustering,
stability, or activity. A, example of a myotube transfected with rapsyn-GFP
and labeled with bungarotoxin-Alexa 594. Shown are representative clusters
in which rapsyn-GFP perfectly co-localizes with acetylcholine receptors. Scale
bar, 20 m. B, untransfected myotubes and myotubes expressing rapsyn-GFP
responded similarly to the application of the AChR agonist, carbachol, and
this response was blocked after the addition of the AChR antagonist, curare,
indicating that AChR function is not disrupted by rapsyn-GFP. C, example of
myotubes expressing different levels of rapsyn-GFP at clusters that were
labeled with anti-rapsyn antibodies and 4⬘,6-diamidino-2-phenylindole
(DAPI) to stain nuclei. Images illustrate that overall rapsyn density is the same
in rapsyn-GFP-expressing clusters and in clusters that do not express rapsynGFP. Scale bar, 20 m. D, histogram showing the mean fluorescence intensity
of anti-rapsyn staining from many clusters of nontransfected myotubes and
myotubes transfected with rapsyn-GFP. Note that the mean fluorescence is
comparable in both transfected and untransfected myotube clusters. Histograms represent mean fluorescent intensity ⫾ S.D. E, quantification of rapsyn
immunofluorescence and rapsyn-GFP for many clusters on transfected myotubes. As shown by the scatter plot, rapsyn-GFP fluorescent expression at
clusters did not correlate with total rapsyn density.

tube cultures. After 4 h, we found that 65 ⫾ 15% (S.D., n ⫽ 29)
of fluorescently labeled AChRs remained at clusters expressing low rapsyn-GFP fluorescence, 60 ⫾ 13% (S.D, n ⫽ 42)
remained at clusters expressing medium rapsyn-GFP, and
62 ⫾ 15% (S.D., n ⫽ 44) remained at clusters expressing high
rapsyn-GFP. These results are similar to fluorescence
remaining after 4 h at AChR clusters expressing no rapsynGFP (63 ⫾ 17% (S.D., n ⫽ 77)) (Fig. 2, A–C). This indicates
that rapsyn-GFP expression has no effect on AChR stability
in our culture system.
VOLUME 282 • NUMBER 13 • MARCH 30, 2007
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FIGURE 2. The cluster expression of rapsyn-GFP has no effect on AChR
removal. Nontransfected myotubes and myotubes transfected with rapsynGFP were labeled with BTX-Alexa 594, and the loss of AChR-BTX-594 was
monitored over 4 h. A, example of clustered AChRs on rapsyn-GFP transfected
myotubes that were labeled with BTX-594, imaged, and imaged again 4 h
later to determine the receptor loss rate. B, clustered AChRs on untransfected
myotubes were labeled as above and also followed over 4 h. C, histogram
summarizes data obtained from many clusters on transfected and untransfected myotubes. Note that the change in fluorescently labeled AChR levels
monitored over 4 h on untransfected myotubes and at myotube clusters
expressing a wide range of rapsyn-GFP were not significantly different (p ⬎
0.3). All values represent mean ⫾ S.D.

Recovery Rate of Rapsyn-GFP at Individual Myotube Clusters—
Having found that rapsyn-GFP has no effect on the clustering,
function, or turnover of AChRs, we wanted to determine the
lifetime of rapsyn at individual clusters. To do this, transfected
myotubes expressing rapsyn-GFP were imaged, and then the
GFP at individual clusters was removed with an argon laser.
MARCH 30, 2007 • VOLUME 282 • NUMBER 13

Confirmation of the removal of fluorescence was done by
acquiring a second image (Fig. 3A). We then monitored the
recovery of fluorescence at bleached clusters over time from a
number of cultures (data from 3–5 culture dishes at each time
point). We found that rapsyn clusters recovered fluorescence
very rapidly, gaining 61 ⫾ 11% (S.D., n ⫽ 40) of original fluorescence after only 2 h, 71 ⫾ 19% (S.D., n ⫽ 56) after 4 h, and
75 ⫾ 18% (S.D., n ⫽ 58) after 6 h (Fig. 3, A and B). The recovery
at each data point was nearly identical for rapsyn-GFP clusters
from myotubes not grown on laminin (2 h: 63 ⫾ 12% (S.D., n ⫽
35); 4 h: 73 ⫾ 17% (S.D., n ⫽ 15); 6 h: 78 ⫾ 21% (S.D., n ⫽ 33))
(Fig. 3, A and B). This recovery was not due to reversible bleaching of GFP, because no fluorescence was observed after bleaching rapsyn-GFP clusters on fixed myotubes. In addition, we
found that the recovery of rapsyn-GFP over 4 h was not affected
by rapsyn-GFP expression levels (Fig. 3C).
Given this rapid rate of rapsyn insertion and past reports
suggesting that rapsyn is co-transported with AChRs to the cell
surface (29, 30), we wanted to determine the rate of AChR
insertion into individual clusters using the same fluorescence
recovery after photobleaching method. To do this, myotubes
were bathed with a single saturating dose of BTX-488, and then
all fluorescence was carefully removed from individual clusters
with an argon laser. After 2, 4, or 6 h, a second dose of BTX-488
was added to label all AChRs that had been inserted into
clusters over this time. We found that 15 ⫾ 4% (S.D., n ⫽ 30)
of original fluorescence was returned to the clusters after 2 h,
25 ⫾ 7% (S.D., n ⫽ 54) after 4 h, and 28 ⫾ 9% (S.D., n ⫽ 39)
after 6 h (data obtained from 3–5 cultures per data point)
(Fig. 3, A and B). The number of AChR molecules inserted
over time was therefore significantly lower than the number
of rapsyn-GFP molecules inserted over the same time period
(see “Discussion”).
Given the large amount of rapsyn-GFP recovery during the
first 2 h, we wanted to monitor more closely the insertion of
rapsyn-GFP immediately after photobleaching. To do this,
rapsyn-GFP clusters on transfected myotubes were bleached,
and time lapse imaging was used to monitor the fluorescent
recovery every 15 min at room temperature. We found that
rapsyn-GFP recovery was 11 ⫾ 4, 17 ⫾ 5, 23 ⫾ 9, and 27 ⫾ 11%
at 15, 30, 45, and 60 min (S.D., n ⫽ 15 clusters/3 culture dishes)
(Fig. 3, D and E). The rapid recovery of fluorescence observed in
clusters is not due to reversible bleaching of the fluorophore,
since rapsyn-GFP clusters on fixed myotubes that are bleached
show no spontaneous fluorescence recovery, even over days
(data not shown). We also found that the labeling of AChRs
with BTX-647 had no effect on rapsyn insertion dynamics,
since rapsyn insertion measured by fluorescence recovery after
photobleaching was identical at rapsyn-GFP-expressing clusters that were not labeled with any BTX and at rapsyn-GFPexpressing clusters that were saturated with BTX-647 prior to
photobleaching (data not shown).
The Clustering of AChRs and Rapsyn Are Altered Similarly by
Agrin Treatment—In order to determine if rapsyn and AChRs
are regulated similarly despite the difference in dynamics, we
attempted to manipulate AChR stability and insertion using the
neuronal clustering factor, agrin. Our previous results showed
that when agrin was added to myotubes grown on a laminin
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Rapsyn is inserted rapidly into individual clusters. A, the insertion of rapsyn-GFP into individual clusters on myotubes grown either on laminincoated dishes or uncoated dishes was measured by determining the fluorescent recovery after photobleaching using quantitative fluorescent imaging. The
insertion of rapsyn-GFP into bleached laminin-associated clusters (top panels) and nonlaminin clusters (middle panels) is rapid and nearly identical over 2 h in
both cases. In contrast, acetylcholine receptor clusters that were labeled with bungarotoxin-Alexa 488, bleached, and then incubated in new bungarotoxin-488
(bottom panels) show far fewer inserted AChRs over the same time period. B, graph summarizes the data from the recovery of rapsyn and AChRs at 2, 4, and 6 h
time points. C, the rate of rapsyn-GFP insertion is independent of the level of rapsyn-GFP expression. D, sample images from a time lapse experiment in which
the fluorescent recovery at a number of clusters was determined every 15 min for 60 min. E, results from three experiments performed as in D (n ⫽ 15 clusters).
Note that the recovery of fluorescence is ⬎25% after 1 h, although cells were maintained at room temperature for the duration of the experiment. All graph
points for B and E represent mean ⫾ S.E., and all data were fit well by single exponential curves. Scale bars, 20 m.

substrate, most new receptors were not directed into preexisting laminin-induced clusters but instead formed numerous
small aggregates on the entire muscle surface (23). Since rapsyn
is required for the clustering of AChRs, and its interaction with
the receptor is highly regulated and increased by agrin (31), we
wanted to know whether newly inserted rapsyn molecules are
also directed away from preexisting laminin-associated clusters
and into new, agrin-induced clusters when agrin is added to the
cultures. To investigate this issue, transfected myotubes
expressing rapsyn-GFP were labeled with BTX-594, imaged,
treated with agrin, and then imaged again 4 and 8 h later. Over
the time course of our study, we found that rapsyn clustering
was altered similarly to AChRs, being directed away from the
same regions on laminin-associated clusters and inserted into
the same agrin-induced clusters (Fig. 4).
Effect of Kinase Inhibition on Rapsyn-GFP and AChR
Dynamics—Having found that AChRs and rapsyn respond
similarly to agrin treatment, we wanted to extend our anal-
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ysis to determine if alterations in kinase activity could affect
rapsyn and AChRs in a similar manner. Previous studies have
shown that agrin-induced clustering of AChRs can be inhibited by the broad spectrum kinase inhibitor, staurosporine
(32–34). To further investigate the role of kinase activity on
receptor and rapsyn dynamics at single clusters, we performed a series of experiments using various kinase inhibitors. As a first step, we used the broad spectrum kinase inhibitor, staurosporine. To study the effect of staurosporine on
receptor insertion, cultured myotubes were labeled with
BTX-488, and clusters were imaged and photobleached.
Cells were then incubated with 20 nM staurosporine, and 4 h
later, the cells were bathed with new BTX-488 to label all
new receptors. We found that the number of AChRs accumulated at bleached clusters was significantly decreased to
18 ⫾ 5% (S.D., n ⫽ 13, p ⬍ 0.0001) of the original receptor
density, compared with 28 ⫾ 6% (S.D., n ⫽ 20) for control
clusters (Fig. 5, A and B).
VOLUME 282 • NUMBER 13 • MARCH 30, 2007
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FIGURE 4. Agrin redirects both AChRs and rapsyn away from preexisting
laminin clusters and into new agrin-induced clusters. Myotubes expressing rapsyn-GFP were incubated with BTX-594 to label all AChRs. Agrin was
then added to the culture medium, and rapsyn and receptors were imaged 4
and 8 h later. Note that both AChRs and rapsyn were directed away from some
locations on the preexisting laminin-associated clusters (arrowheads) and
were also aggregated together into new, agrin-induced clusters (arrows).
Scale bar, 20 m.

Since staurosporine inhibits PKC, PKA, and other kinases,
we wanted to more specifically determine the effect of PKA and
PKC on receptor insertion. To do this, myotubes were labeled
with BTX-488 as above, and the recovery of fluorescence in
bleached clusters was monitored in the presence of 100 nM
H-89 (to specifically block PKA), 20 nM H-89 (to block PKA and
PKC), or 10 nM calphostin C (to specifically block PKC). We
found that 100 nM H-89 had no effect on receptor insertion
(27 ⫾ 8% (S.D., n ⫽ 20)) compared with controls. However, in
the presence of 20 M H-89, the accumulation of new receptors
at bleached clusters decreased to 23 ⫾ 4% (S.D., n ⫽ 21, p ⬍
0.005). Similar results were obtained when PKC was more specifically inhibited by 10 nM calphostin C (21 ⫾ 6% (S.D., n ⫽ 20,
p ⬍ 0.005)). At higher concentration of calphostin C (⬎50 nM),
most cells were dead after 4 h. These experiments suggest that
PKC activity is somehow involved in the insertion of receptors
(Fig. 5B).
Next we asked whether AChR loss was also affected by kinase
inhibition. To answer this question, cells were labeled with
BTX-488, and individual receptor clusters were imaged and
then incubated with one of the same drugs used in the above
experiments before being imaged again at 4 h. At clusters on
untreated control myotubes, 72 ⫾ 8% (S.D., n ⫽ 15) of origiMARCH 30, 2007 • VOLUME 282 • NUMBER 13

nal fluorescence remained after 4 h. When cells were treated
with 100 nM H-89, 20 M H-89, or 10 nM calphostin C, there was
no difference in receptor loss compared with control (68 ⫾ 9%
(S.D., n ⫽ 23), 71 ⫾ 10% (S.D., n ⫽ 10), 73 ⫾ 12% (S.D., n ⫽ 20))
(Fig. 5D). However, incubation in 20 nM staurosporine resulted
in an increase in receptor removal from clusters, with only 52 ⫾
10% (S.D., n ⫽ 21, p ⬍ 0.0001) of original fluorescence remaining at clusters after 4 h (Fig. 5, C and D). These results suggest
that staurosporine, in addition to inhibiting AChR insertion,
increases receptor removal from clusters in a non-PKC/PKAdependent manner.
Finally, we investigated whether rapsyn-GFP insertion is
similarly affected by kinase inhibition. To do this, myotubes
expressing rapsyn-GFP at clusters were imaged, and the fluorescence was removed from individual clusters using an argon
laser. Bleached clusters were then imaged; staurosporine (20
nM), H-89 (100 nM or 20 M), or calphostin C (10 nM) was added
to the cultures, and the rate of rapsyn-GFP insertion into the
bleached clusters was determined at 4 h. We found that
bleached clusters regained 67 ⫾ 15% (S.D., n ⫽ 37), 64 ⫾ 15%
(S.D., n ⫽ 10), 67 ⫾ 15% (S.D., n ⫽ 16), and 76 ⫾ 11% (S.D., n ⫽
19) of their original fluorescence, respectively (Fig. 5, E and F).
The insertion at bleached clusters was normalized to the
changes in expression (if any) at control, unbleached clusters on
the same myotube. It should be noted that higher concentrations (200 nM) of staurosporine did result in a significant
decrease in rapsyn-GFP insertion over 2 h (clusters were too
dim to be imaged after 4 h) that was similar to the decrease in
AChR insertion measured over the same time period. However,
it seems likely that this was due to decreased cell viability, as has
been observed previously (34).

DISCUSSION
In this study, we investigated the dynamics of rapsyn in cultured myotubes and found that rapsyn is remarkably dynamic
compared with AChRs. Further, although the localization of
both rapsyn and receptor were similarly affected by agrin treatment, their dynamics were differentially regulated by kinase
inhibition.
One unexpected finding from this work is the rapid recovery
of rapsyn-GFP fluorescence at individual clusters after photobleaching. For a number of reasons, we believe that the fused
GFP is not interfering with rapsyn function and that the recovery in fluorescence observed in our studies therefore reflects
the turnover rate of rapsyn. First, it has been shown previously
that the rapsyn-GFP construct used in the present studies is
indistinguishable from wild-type rapsyn in its ability to associate with and cluster AChRs in heterologous cells (27). Second,
the present work demonstrates that rapsyn-GFP expression at
clusters does not alter receptor function, clustering or turnover
in muscle cells. Third, the rapid recovery of fluorescence after
photobleaching was independent of rapsyn-GFP expression at
myotube clusters (Fig. 3). Finally, the accumulation of rapsynGFP at clusters was regulated by agrin in a similar manner as
AChRs. Consistent with these observations, it has been shown
that fluorescent rapsyn also recovers rapidly after photobleaching in QT-6 cells (28). The remarkable dynamism of rapsyn at
surface clusters is further supported by biochemical studies
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Kinase inhibitors alter AChR dynamics but not the dynamics of rapsyn-GFP. Laminin-associated clusters on rapsyn-GFP transfected myotubes
were bleached, and on nontransfected myotubes, AChRs were labeled with BTX-488 before bleaching individual clusters. Cells were then incubated in either
100 nM H-89, 20 M H-89, 10 nM calphostin C, or 20 nM staurosporine. Myotubes were imaged, and the fluorescence at each cluster was compared with its
original fluorescence. A, example of clusters that were bleached on either control or 20 nM staurosporine-treated myotubes. B, graph summarizes data obtained
from many clusters in untreated control cultures and in cultures incubated with one of the above drugs. Note that PKA inhibition alone had no effect on AChR
insertion, whereas the blockade of PKC (with higher concentrations of H-89 and with calphostin C) resulted in a significant decrease in AChR insertion.
Inhibition of a broader spectrum of kinases along with PKC by staurosporine caused a slightly greater inhibition of AChR insertion. C, representative clusters
showing loss of receptors from control myotubes or myotubes treated with 20 nM staurosporine. D, AChR loss from individual clusters in the presence of the
same kinase inhibitors shows that only incubation with staurosporine caused a decrease in overall receptor density remaining at clusters after 4 h, indicating
that the blockade of kinases other than PKA and PKC with staurosporine treatment resulted in the accelerated removal of AChRs from clusters. E, representative
images of control and staurosporine-treated myotubes that are expressing rapsyn-GFP. F, clusters expressing rapsyn-GFP were bleached, and the insertion of
rapsyn was measured by determining the recovery in fluorescence over time in the presence of the same drugs as used above. Note that the insertion of
rapsyn-GFP was not altered by any of the drug treatments. Insertion into clusters was normalized to the changes in fluorescence at neighboring, unbleached
clusters on the same myotube. All bar graphs represent mean ⫾ S.D. *, p ⬍ 0.005; **, p ⬍ 0.0001 (Student’s t test). Scale bars, 10 m.

that show that the metabolic turnover of rapsyn is short compared with AChRs, with a metabolic half-life of ⬃3 h (35). Since
our studies were done on aneural receptor clusters, it is possible
that the turnover of rapsyn might be decreased under the influence of the nerve. Further studies investigating the dynamics of
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rapsyn at the neuromuscular junction will be necessary to
determine if rapsyn is indeed stabilized by innervation.
Although we cannot definitively exclude the possibility that
GFP may diminish the affinity of rapsyn for the AChR or other
scaffold proteins, these results argue strongly that rapsyn-GFP
VOLUME 282 • NUMBER 13 • MARCH 30, 2007
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behaves as endogenous rapsyn and that rapsyn therefore turns
over very rapidly in muscle cells.
Similar to our findings that the acetylcholine receptor-associated protein turns over more rapidly than AChRs, recent
studies on the turnover of receptor-associated proteins at glutamatergic synapses have yielded analogous results. For example, PSD-95, a dynamic protein affiliated with the AMPA and
NMDA receptors (36 – 41), when tagged with GFP and measured with fluorescence recovery after photobleaching, was
shown to turn over very rapidly relative to the glutamate receptors with which it associates (42, 43). This result opens the
possibility that the rapid turnover of rapsyn observed in muscle
cells in the present study may be similar to the behavior of
receptor-associated proteins in the central nervous system.
Previously it has been shown that AChRs and rapsyn are
transported together in the same intracellular vesicles from the
Golgi complex to the membrane surface both in COS cells cotransfected with AChRs and rapsyn and at the mature torpedo
electric organ (a structure analogous to the mammalian neuromuscular junction) (29, 30). Although the ratio of rapsyn to
receptor during intracellular trafficking remains undetermined, estimates from our results suggest that multiple rapsyn
molecules may accompany each AChR to the membrane surface in aneural myotubes.
In addition to highlighting the difference in turnover
between receptors and rapsyn, the present study also shows
that the expression of exogenous rapsyn at clusters does not
increase receptor stability. The effect of exogenous rapsyn on
AChR dynamics has previously been studied in heterologous
cells. In these studies, the effect of rapsyn on AChR stability was
determined by comparing the degradation of radioactive bungarotoxin in heterologous cells devoid of endogenous rapsyn
with cells transfected with rapsyn cDNA (15, 29, 30). They
found that the metabolic half-life of receptors was increased
upon co-expression with rapsyn. A recent study also indicates
that the overexpression rapsyn through electroporation of
rapsyn-GFP into muscle cells in vivo can stabilize receptors
(28). This in vivo result is further supported by findings that
mutant rapsyn results in a decrease in receptor stability in some
forms of myasthenia gravis (21). By contrast, our results indicate that rapsyn-GFP expression at clusters did not alter AChR
stability. This result can be explained by two possibilities. First,
it is conceivable that that exogenous rapsyn-GFP is able to
replace endogenous rapsyn at clusters without increasing
rapsyn density, as demonstrated by quantitative immunofluorescence (Fig. 1, C–E). It is also possible that despite the strong
GFP fluorescence signal, the number of exogenous rapsyn-GFP
molecules inserted at clusters was negligible compared with the
density of endogenous rapsyn. It is important to mention that
the anti-rapsyn antibody used for assaying the total rapsyn content has been shown to recognize both endogenous rapsyn and
exogenous rapsyn-GFP (28).
Despite the difference in turnover between rapsyn and
AChRs, our work indicates that both rapsyn and AChRs are
subject to similar modulation following treatment with neural
agrin. Previously, work from our laboratory has shown that
when AChRs at laminin-associated clusters are treated with
agrin, most new receptors are not directed into preexisting
MARCH 30, 2007 • VOLUME 282 • NUMBER 13

laminin-induced clusters but instead form numerous small
aggregates on the entire muscle surface (23). The present work
extends this observation and demonstrates that when agrin is
added to myotubes, rapsyn-GFP is directed into the new aggregates to co-localize with AChRs, suggesting that rapsyn and
AChRs are responding to agrin similarly and simultaneously. It
is possible that the redirection of AChRs into small aggregates
is driven by the rapsyn, since rapsyn is the bridge between biological activity following agrin treatment and receptor clustering. This idea is supported by experiments showing that AChRs
fail to associate with cytoskeletal proteins in agrin-treated myotubes devoid of rapsyn (17, 18). In fact, AChRs fail to cluster at
all in vitro or in vivo when rapsyn is not present (19, 27, 44). On
the other hand, there is also reason to believe that rapsyn could
instead follow AChRs to clusters. For example, in the absence of
receptors, rapsyn fails to cluster (45, 46).3
Although rapsyn and AChR are intimately associated and
similarly directed by agrin, the mechanisms regulating their
delivery and removal from individual clusters are at least partially distinct. Although PKA inhibition with 100 nM H-89 had
no effect on the insertion of rapsyn or AChRs or on the loss of
AChRs from individual clusters, inhibition of PKC with higher
concentrations of H-89 (20 M) or 10 nM calphostin C significantly decreased AChR insertion without affecting AChR loss
or rapsyn insertion. The broad spectrum kinase inhibitor staurosporine was able to further decrease AChR insertion and
resulted also in an increase in AChR removal without altering
rapsyn insertion. Previous work has shown that the in vivo inhibition of PKC by calphostin C injection retards the development of neuromuscular synapses (47). Although our cells are
aneural, they were plated on laminin, which has been shown to
mimic, at least in some respects, the development of the neuromuscular junction (48). Therefore, it is possible that the
mechanism by which PKC inhibition decreases AChR insertion
in our system could account for the alterations in postsynaptic
growth observed when PKC is blocked in vivo by the same pharmacological agent. The fact that staurosporine increases the
removal of AChRs in addition to decreasing their insertion
implies that staurosporine may act to increase AChR dispersal
through a non-PKA/PKC-dependent mechanism. In support of
this conclusion, it has been shown previously that non-PKCdependent tyrosine phosphorylation contributes to receptor
clustering. For example, Src class kinases promote the phosphorylation of the ␤ subunit and increase the association of
AChRs with the intracellular cytoskeleton (3, 15, 16, 49), and
agrin-induced receptor clusters are removed rapidly in the
absence of Src class kinases (15).
Our results show that rapsyn-GFP insertion was not affected
by any of the kinase inhibitors used. This may indicate that the
synthesis and delivery of rapsyn to individual clusters is independent of the phosphorylation either of rapsyn or of proteins
that are necessary for rapsyn exocytosis. Previous reports have
shown that receptors and rapsyn are co-transported in the
same vesicle and inserted into the plasma membrane. It is possible that the difference in the amount of receptor and rapsyn
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insertion when cultured cells were treated with PKC inhibitor
could therefore be due to the selective impairment of receptor
transcription.
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